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Tuesday, February 18, 2014 551aOur results point to KCa1.1 channels as a promising new target for RA
therapy and open the possibility for treatments that would not induce
immunosuppression.
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Voltage-gated Kþ channels (Kv) are responsible for myoblasts proliferation
and differentiation by triggering changes in membrane potential and cell
volume. Since individuals with myotonic dystrophy type 1 (DM1) display
reduced myogenesis led by prolonged myoblasts proliferation and delayed
myotubes fusion, we investigated the roles of Kþ channels in primary human
myoblasts obtained from DM1 patients and healthy volunteers. DM1 is an
autosomal dominant neuromuscular disorder affecting 1 in 8000 people world-
wide. It is the most common adult-onset muscular dystrophy and currently
has no treatment. DM1 is characterized by muscle wasting and multi-system
disorders.
We have identified a switch in functional potassium channel expression from
KCa1.1 to Kv1 channels when comparing myoblasts from healthy individuals
to myoblasts from patients with DM1. We showed increase in Kv1.2 and Kv1.5
channels, and decrease in KCa1.1 channels in DM1 myoblasts at mRNA level
by RT-PCR, at protein level by immunofluorescence, and at channel activity
by patch-clamp technique. We hypothesized that this switch in Kþ channels
plays a role in the reduced myogenesis observed in patients with DM1, and
that selective inhibition of Kv1 channels rescues the pathological features of
DM1 in skeletal muscle.
We show that pharmacological inhibition of Kv1 channels in DM1 myoblasts
normalized proliferation, rescued matrix metalloproteinase-2 (MMP-2, a
protease necessary for myotube fusion) production, and partially rescued
myotube fusion shown as increase in fusion index. On the contrary, selective
inhibition of KCa1.1 in normal myoblasts lowered MMP-2 production,
impaired wound healing repair, and decreased myotubes formation. Therefore
we conclude that loss of KCa1.1 and up-regulation of Kv1 channels in DM1
impairs early stage of myogenesis and can be partially rescued by modulating
such Kþ channels.
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The Smith-Lemli-Opitz syndrome (SLO) is a multiple congenital anomaly,
caused by a decreased or abolished activity of 7-dehydrocholesterol (7DHC)
reductase, which results in the accumulation of the cholesterol precursor
7DHC in the serum and potentially in the cell membrane as well. Increased
7DHC/cholesterol ratio may modify the physico-chemical properties of plasma
membrane, and hence may influence the operation of the ion channels in many
cell types including T cells. To test this hypothesis we compared the biophys-
ical properties of Kv1.3 channels in T cells of SLO patients (SLO-T-cells),
T-cells of healthy volunteers loaded with 7DHC (7DHC-T-cells) and control
T cells. The physiological consequence of altered Kv1.3 gating was measured
by the proliferative capacity of CD3þ lymphocytes.
T lymphocytes were isolated from the peripheral blood of healthy volunteers
(age-matched controls) and patients with SLO. 7DHC elevation in T lympho-
cytes membrane was achieved upon treatment with cyclodextrin/7DHC
complex. Kv1.3 currents were measured using whole-cell patch-clamp. Prolif-
eration rate of lymphocytes was assessed with CFSE-dilution assay upon anti-
CD3/anti-CD28 stimulation.
Our results showed that both activation and inactivation kinetics were signifi-
cantly slower, and the midpoint of the steady-state activation was shifted
toward positive voltages in the SLO-T-cells compared to control (taua,SLO:
0.72 ms, taua,c: 0.60 ms ; taui,SLO: 238,48 ms, taui,c : 213,19 ms; V1/2,SLO : -
21.762 mV ,V1/2,c : - 27.98 mV). Qualitatively and quantitatively differences
in the gating of Kv1.3 channels were observed in 7DHC-T-cells vs. control.
T-cells from SLO patients had decreased proliferation rate as compared to
healthy controls. These data demonstrate that elevated 7DHC level of cell
membrane can modify the operation of ion channels and may contribute to
the neurodegenerative defects in SLO. (Mecenatura OSTRAT/260/2012,
TA´MOP 4.2.4.A/2-11-1-2012-0001).2789-Pos Board B481
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The causative agent of malaria is the unicellular protozoan Plasmodium. The
parasite has a complex life cycle, involving asexual replication in human red
blood cells (RBCs) as well as sexual replication, forming egg-like cells called
oocysts in the mosquito vector. In endemic areas it is estimated that 250 million
people get infected with malaria annually, resulting in 500.000-1.000.000
deaths. Increasing resistance towards known antimalarial drugs poses a signif-
icant problem in the fight against malaria. Therefore, the development of novel
drugs that target vital proteins encoded by the parasite has attracted major atten-
tion. Plasmodium falciparum, the species responsible for the majority of
malaria- associated fatalities, encodes two putative Kþ channels, PfKch1 and
PfKch2, which have been cloned in our laboratories. Although viable in all
intraerythrocytic stages, Kch1-null P. berghei parasites exhibit a total inhibition
of oocyst development in the mosquito midgut. Thus, Kch1 might serve as a
potential target in novel parasite transmission-blocking strategies. However,
earlier published immunofluorescence microscopy images have suggested
that Kch1 is located in the infected human red blood cell membrane. In the pre-
sent study, polyclonal antibodies were raised against the PfKch1 channel and
our results demonstrate that Kch1 is located in the parasites plasma membrane
in all blood stages of malaria. This finding is in accordance with functional data
previously published from our lab. Thus, Kch1 may be a major Kþ transporter
in the parasite plasma membrane and play an important role for regulation of
the membrane potential of the Plasmodium parasite.
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Acute lymploblastic leukemia (ALL) is the most common malignancy in child-
hood and young adolescence, comprising about 30% of all cancers. Despite the
fact that treatment strategies have strongly improved in the last decades, ALL is
still one of the major causes of cancer-related death in children. Whilst the sub-
types of ALL deriving from B cells are already well described by their genetic
and molecular features, the biology of the T cell-linage (T-ALL) is very hetero-
geneous and with the exception of some frequently occurring genetic aberra-
tions until now poorly understood.
By controlling the membrane potential, Kþ channels regulate Ca2þ signaling
and subsequent proliferation in human lymphocytes. Expression levels of the
two major Kþ channels found in lymphocytes (Kv1.3 and KCa3.1) are
subtype-specific. The more abundantly expressed channel typically dominates
the Ca2þ signaling events that result in proliferation. This renders the cells
sensitive to specific blockade of this more highly expressed Kþ channel. We
investigated lymph node and bone marrow samples of T-ALL patients and
found high expression levels of Kv1.3 channels in malignant T-lymphoblasts,
confirmed by immunohistochemistry and immunofluorescence microscopy.
Moreover, we also detected high Kv1.3 currents in a T-ALL cell line
(Molt-4) compared to low KCa.3.1 currents, which was confirmed by mRNA
data, as well as fluorescence microscopy. The functional role of Kv1.3 in pro-
liferation of malignant T-lymphoblasts was elucidated by the pharmacological
blockade of Kv1.3. Proliferation rates were significantly diminished by treat-
ment with PAP-1 and ShK-L5 (specific blockers for Kv1.3 channels) but not
by TRAM-34 or ICA-17043 (specific blockers for KCa3.1). Further investiga-
tion might thus suggest a role for Kv1.3 channels in the treatment of T-ALL.
Supported by RO1 GM076063 from the National Institute of Health and the
Austrian National Bank Jubilaeumsfons No. 14311.
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Ion channel inhibitor peptide toxins have become lead compounds for potential
therapeutic use in the last decade. In the case of Kv1.3, the voltage-gated Kþ
